Cell line · CVCL_5916
Rh4
Cancer cell line, Homo sapiens. Alveolar rhabdomyosarcoma. 21 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. Rh4. Cell lines, record CVCL_5916. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_5916
On this page
Cell line
As Cellosaurus gives it.
- Name
- Rh4
- Accession
- CVCL_5916
- RRID
- RRID:CVCL_5916
- Synonyms
- RH4, Rh-4, SJRH-4, SJRH4, SJ-RH4, SJ-Rh 4
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 7Y
- Category
- Cancer cell line
- Diseases
- Alveolar rhabdomyosarcoma (NCIt C3749); Alveolar rhabdomyosarcoma (ORDO Orphanet_99756)
- Secondary accessions
- CVCL_L416
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers21
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Seclidemstat (SP-2577) Induces Transcriptomic Reprogramming and Cytotoxicity in Multiple Fusion-Positive Sarcomas. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| MyoD is essential in rhabdomyosarcoma by promoting survival through differentiation and CYLD. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| PubMed 40777370 | bioRxiv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer. | Mol Cancer Ther | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. | Int J Mol Sci | 2023 | Cellosaurus cites it | PubMed | |
| Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. | Sci Adv | 2023 | Its Methods give the RRID and name the line | PubMed | |
| SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia. | Cell Rep | 2022 | Its Methods give the RRID and name the line | PubMed | |
| FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas. | Mol Oncol | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer. | Cancer Discov | 2021 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 21
See all 21 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| From the same person | Rh41 | CVCL_2176 |
Source Cell lines
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_5916
GET https://conductscience.org/api/cell-lines/v1/CVCL_5916/papers?page=2